Century Therapeutics Inc (IPSC) — Cash Flow Reinvestment Rate
Century Therapeutics Inc (IPSC) has a Cash Flow Reinvestment Rate of 0.51x as of March 2022, reinvesting $44.04 Million (capex $4.07 Million plus investments $-39.97 Million) from operating cash flow of $86.75 Million. Explore IPSC capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Century Therapeutics Inc Cash Flow Reinvestment Rate (2015–2022)
Historical reinvestment intensity for Century Therapeutics Inc across 2 annual periods. Also explore total assets of Century Therapeutics Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Century Therapeutics Inc (2015–2022)
Year-by-year capital reinvestment analysis for Century Therapeutics Inc. For live market cap and broader valuation context, see IPSC market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 3.42x | $48.08 Million | $14.05 Million | $30.60 Million | ▲ +1114.0% |
| 2015 | 0.28x | $29.39 Million | $104.30 Million | $29.39 Million | — |